Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released Aug 8, 2023, before the open
10-Q filed Aug 9, 2023, 40 days after period end · 0001558370-23-014242
| Metric | Q2 2023 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $107.38M | $102.22M | $81.11M | $65.08M |
| Net Income | -$1.06B | $12.28M | -$49.38M | -$44.22M |
| EPS Diluted |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| -$6.84 |
| $0.08 |
| -$0.32 |
| -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.